🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A significant proportion of patients with localized prostate cancer, and tr...
Status
Completed
Location
Service d'Urologie et Chirurgie de la Transplantation - Hôpital Edouard Herriot - Hospices Civils de Lyon
Start Date
2020-06-23
Trial ID
NCT03927521
Treatments Being Tested
The study is an open label, non-randomized study designed to evaluate the d...
Status
Terminated
Location
Johns Hopkins University
Start Date
2019-11-15
Trial ID
NCT03619655
Treatments Being Tested
Prospective single-center one-arm phase II study in patients with prostate ...
Status
Recruiting
Location
Medical University of Vienna
Start Date
2024-01-15
Trial ID
NCT06220188
Treatments Being Tested
This is a phase 2, open-label, randomized study of adjuvant treatment in su...
Status
Recruiting
Location
Dept of Surgical Sciences - Urology, Molinette Hospital, University of Torino
Start Date
2024-11-25
Trial ID
NCT06758882
Treatments Being Tested
The main goal of this phase II clinical trial is to define a novel approach...
Status
Unknown
Location
IRCCS Ospedale San Raffaele
Start Date
2020-09-09
Trial ID
NCT06484361
PD1-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University
Start Date
2021-12-23
Trial ID
NCT04768608
Treatments Being Tested
The purpose of this study is to evaluate the change in the expression of tr...
Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Start Date
2024-07-29
Trial ID
NCT06379217
This study aims to evaluate safety and efficacy of a combination of 4th gen...
Status
Not Yet Recruiting
Location
Shenzhen Geno-Immune Medical Institute
Start Date
2027-06-01
Trial ID
NCT04429438
Treatments Being Tested
The goal of this observational study is to evaluate the diagnostic efficacy...
Status
Unknown
Location
IEO European Institute of Oncology
Start Date
2022-03-21
Trial ID
NCT05596851
Glioblastoma (GBM) comprises about 16% of all malignancies of the nervous s...
Status
Withdrawn
Location
John Wayne Cancer Institute
Start Date
2016-09
Trial ID
NCT02876003
Treatments Being Tested